The Nanowear Wearable Covid-19 Observational and Analysis Trend
Recruiting
- Conditions
- Covid19
- Registration Number
- NCT04717024
- Lead Sponsor
- Nanowear Inc.
- Brief Summary
The NanoCOAT study is a multi-center, prospective, non-randomized, feasibility, observational, non-significant risk study. The NanoCOAT study will enroll a minimum of 10 and a maximum of 100 subjects in a potential for a multi-site in order to collect data and analyze physiological and biometric trends due to Covid-19.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- Subject has provided informed consent
- Male or female over the age of 18 years
- The patient is currently hospitalized with a primary diagnosis of Covid-19
Exclusion Criteria
- Subject is unwilling or unable to wear the vest during hospitalization.
- Subjects who are pregnant.
- Subject is intubated or admitted to ICU
- Subject has an implantable cardiac device (i.e pacemaker or internal cardioverter defibrillator)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hosptialized patient data up to 30 days of monitoring leading to discharge or admission to ICU The primary study endpoint is adequate collection of hospitalized COVID 19 patient health metric data through the Nanowear WMDRS
- Secondary Outcome Measures
Name Time Method Trends in COVID 19 exacerbation up to 30 days of monitoring leading to discharge or admission to ICU Exploratory information will be used to compare the signals obtained from the device to the severity of Covid-19 as measured by clinical evaluation
Trial Locations
- Locations (2)
Hackensack University Medical Center
🇺🇸Hackensack, New Jersey, United States
Maimonides Medical Center
🇺🇸Brooklyn, New York, United States